Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Coe%2C+Faye%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Coe%2C+Faye%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Coe%2C+Faye%22&type=Person&sort=year
PubPharm (7)
1
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
enthalten in:
Breast cancer research and treatment
| 2022
von
Coe, F.
|
Misra, V.
|
McCabe, Y.
| +6
Wird geladen...
2
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
enthalten in:
Breast cancer research and treatment
| 2021
von
Coe, F.
|
Misra, V.
|
McCabe, Y.
| +6
Wird geladen...
3
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
enthalten in:
Breast cancer research and treatment
| 2021
von
Coe, F.
|
Misra, V.
|
McCabe, Y.
| +6
Wird geladen...
4
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
enthalten in:
Breast cancer research and treatment
| 2020
von
Howell, S.
|
Coe, F.
|
Wang, X.
| +2
Wird geladen...
5
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
enthalten in:
Breast cancer research and treatment
| 2020
von
Howell, S.
|
Coe, F.
|
Wang, X.
| +2
Wird geladen...
6
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
enthalten in:
Breast cancer research and treatment
| 2020
von
Howell, S.
|
Coe, F.
|
Wang, X.
| +2
Wird geladen...
7
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
enthalten in:
Breast cancer research and treatment
| 2020
von
Howell, S.
|
Coe, F.
|
Wang, X.
| +2
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
7
Aufsätze
5
E-Artikel
5
E-Ressourcen
2
Gedruckte Aufsätze
Zeitschriftentitel
7
Breast cancer research and treatment
Thema
4
Administration and dosing
4
Breast neoplasms
4
Carboplatin
4
Neoadjuvant therapy
4
Treatment outcome
3
Chemotherapy
3
Eribulin
3
Metastatic breast cancer
3
Palliative
3
Real world
3
Subtypes
2
Journal Article
1
15H5577CQD
1
Antibodies, Monoclonal, Humanized
1
BG3F62OND5
1
Docetaxel
1
EC 2.7.10.1
1
Furans
1
K16AIQ8CTM
1
Ketones
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2022
2
2021
4
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7
Englisch
Haven't found what you're looking for?
Wird geladen...